1,2-丙醇利用细菌微胶囊在体内的活性数学建模
Mathematical modeling of 1,2-propanediol utilization bacterial microcompartments in vivo activity
AI总结:
该研究通过数学建模揭示了1,2-丙二醇利用细菌微胶囊在体内的活性机制,指出胞质酶活性对代谢通量的影响,并修正了体内代谢模型。
摘要:
在暴露于1,2-丙二醇(1,2-PD)时,沙门氏菌伤寒亚种LT2产生1,2-PD利用(Pdu)微胶囊(MCPs),这些是纳米级的蛋白质结合壳,包裹代谢酶。MCPs作为一种生物工程平台,用于研究反应组织并增强特定通路的流量。然而,最近一篇关于纯化野生型(WT)MCPs的实验报告的代谢活性与体内观察到的有显著差异。通过动力学建模,我们将这些差异归因于体内的细胞生长以及MCP相关酶和兼性酒精脱氢酶存在于胞质中,而这些在纯化的MCPs中不存在。使用纯化的MCPs在大肠杆菌裂解液中的实验,以及在LT2生长实验中敲除原生Pdu MCP相关酒精脱氢酶PduQ的实验,支持了结论,即外源性Pdu胞质酶活性可以缩小体外和体内实验之间的差距。我们的建模进一步表明,MCP局部化的酶对PduCDE下游的体内代谢流量贡献很小。因此,我们提出了一种修订的体内WT在1,2-PD上的生长模型,在该模型中PduCDE被完全封装,而大部分下游Pdu活性发生在胞质中。
英文摘要:
On exposure to 1,2-propanediol (1,2-PD), Salmonella enterica serovar Typhimurium LT2 produces 1,2-PD utilization (Pdu) microcompartments (MCPs), nanoscale protein-bound shells that encapsulate metabolic enzymes. MCPs serve as a bioengineering platform to study reaction organization and enhance flux through specific pathways. However, a recently published assay of purified wild-type (WT) MCPs reported metabolic activity that differed markedly from that observed in vivo. Using kinetic modeling, we attribute these discrepancies to in vivo cell growth and to the cytosolic presence of MCP-associated enzymes and promiscuous alcohol dehydrogenases, which are not present in the purified MCPs. Assays of purified MCPs in E. coli lysate, together with an LT2 growth assay in which the native Pdu MCP-associated alcohol dehydrogenase, PduQ, was knocked out, support the conclusion that exogenous Pdu cytosolic enzyme activity can narrow the gap between in vitro and in vivo experiments. Our modeling further suggests that MCP-localized enzymes contribute little to in vivo metabolic flux downstream of PduCDE. We therefore propose a revised in vivo model of WT growth on 1,2-PD in which PduCDE is fully encapsulated, while much of the downstream Pdu activity occurs in the cytosol.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。